Clinical Trials

Study #2019-0937
A Multicenter Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue Lesions

Study #2019-1234
Cryoablation combined with stereotactic body radiation therapy for the treatment of painful bone metastases

Study #2018-0301
Ablation of Lung Lesions Using Microwave Energy (ALLUME)

Study #PA18-1012
A prospective lab study to detect cytogenetically abnormal cells in patients with lesions or masses suspicious for primary lung cancer

Study #2020-1255
High Dose-Rate Brachytherapy for the Treatment of both Primary and Secondary Unresectable Liver Malignancies

Study #2021-0171
A prospective, multicenter, open-label single arm study evaluating the safety and efficacy of selective internal radiation therapy (SIRT) using SIR-Spheres® Y-90 resin microspheres on duration of response (DoR) and objective response rate (ORR) in unresec

Study #2022-0221
Stereotactic Liver Ablation Assisted with Intra-Arterial CT Hepatic Arteriography and Ablation Confirmation Software Assessment (STEREOLAB)

Study #2022-0438
Ablation with confirmation of colorectal liver metastases (ACCLAIM) prospective trial for microwave ablation as a local cure

Study #2022-0052
A prospective study of conventional bone marrow biopsies and bone marrow biopsies performed through an indwelling bone marrow port, using a modified PROMIS pain intensity scale for pain assessment

Study #2022-0769
TriNav Infusion System for the Evaluation of Fidelity between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning (Tri-FY90)

Study #2023-0396
A phase III, randomized, open-label, sponsor-blinded, multicenter study of Durvalumab in combination with Tremelimumab +/- Lenvatinib given concurrently with Transarterial Chemoembolization (TACE) Compared to TACE alone in patients with Locoregional Hepatocellular Carcinoma (EMERALD-3)